Literature DB >> 29654449

Transcatheter valve interventions in heart failure: new answers to old questions.

Marijana Tadic1, Cesare Cuspidi2.   

Abstract

Heart failure (HF) is often associated with different valve diseases, predominantly functional mitral and tricuspid regurgitation. However, the association between HF and aortic stenosis, particularly low-flow low-gradient aortic stenosis, is not infrequent. Severe mitral and tricuspid regurgitations, as well as aortic stenosis, in HF patients worsen prognosis and left ventricular dilatation and induce further reduction in left ventricular ejection fraction. Transcatheter edge-to-edge mitral and tricuspid valve repair and transcatheter aortic valve implantation could be an important therapeutic option with a satisfactory long-term outcome in HF patients with comorbidities and even in patients with severely depressed ejection fraction.

Entities:  

Keywords:  Heart failure; MitraClip; Mitral annuloplasty; Transcatheter aortic valve interventions; Tricuspid annuloplasty

Mesh:

Year:  2018        PMID: 29654449     DOI: 10.1007/s10741-018-9701-4

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  56 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

2.  Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique.

Authors:  Daniel Braun; Michael Nabauer; Mathias Orban; Martin Orban; Lisa Gross; Andrea Englmaier; Diana Rösler; Julinda Mehilli; Axel Bauer; Christian Hagl; Steffen Massberg; Jörg Hausleiter
Journal:  EuroIntervention       Date:  2017-02-03       Impact factor: 6.534

3.  Treatment of Heart Failure With Associated Functional Mitral Regurgitation Using the ARTO System: Initial Results of the First-in-Human MAVERIC Trial (Mitral Valve Repair Clinical Trial).

Authors:  Jason H Rogers; Martyn Thomas; Marie-Claude Morice; Inga Narbute; Milana Zabunova; Thomas Hovasse; Mathieu Poupineau; Ainars Rudzitis; Ginta Kamzola; Ligita Zvaigzne; Samantha Greene; Andrejs Erglis
Journal:  JACC Cardiovasc Interv       Date:  2015-06-24       Impact factor: 11.195

4.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

5.  Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.

Authors:  Edward T Carreras; Tsuyoshi Kaneko; Fernando Ramirez-Del Val; Marc P Pelletier; Piotr S Sobieszczyk; Deepak L Bhatt; Pinak B Shah
Journal:  Catheter Cardiovasc Interv       Date:  2017-10-08       Impact factor: 2.692

Review 6.  Diagnosis and treatment of tricuspid valve disease: current and future perspectives.

Authors:  Josep Rodés-Cabau; Maurizio Taramasso; Patrick T O'Gara
Journal:  Lancet       Date:  2016-04-02       Impact factor: 79.321

7.  One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation.

Authors:  Sven T Pleger; Marius Schulz-Schönhagen; Nicolas Geis; Derliz Mereles; Emmanuel Chorianopoulos; Muliadi Antaredja; Markus Lewening; Hugo A Katus; Raffi Bekeredjian
Journal:  Eur J Heart Fail       Date:  2013-03-19       Impact factor: 15.534

8.  Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).

Authors:  Sammy Elmariah; Igor F Palacios; Thomas McAndrew; Irene Hueter; Ignacio Inglessis; Joshua N Baker; Susheel Kodali; Martin B Leon; Lars Svensson; Philippe Pibarot; Pamela S Douglas; William F Fearon; Ajay J Kirtane; Hersh S Maniar; Jonathan J Passeri
Journal:  Circ Cardiovasc Interv       Date:  2013-11-12       Impact factor: 6.546

9.  Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial.

Authors:  Francesco Maisano; Maurizio Taramasso; Georg Nickenig; Christoph Hammerstingl; Alec Vahanian; David Messika-Zeitoun; Stephan Baldus; Michael Huntgeburth; Ottavio Alfieri; Antonio Colombo; Giovanni La Canna; Eustachio Agricola; Michel Zuber; Felix C Tanner; Yan Topilsky; Felix Kreidel; Karl-Heinz Kuck
Journal:  Eur Heart J       Date:  2015-11-18       Impact factor: 29.983

10.  Left ventricular ejection fraction of < 20%: Too bad for MitraClip© ?

Authors:  Sebastian Barth; Martina B Hautmann; Sebastian Kerber; Frank Gietzen; Wilko Reents; Michael Zacher; Philipp Halbfass; Daniel P Griese; Bernhard Schieffer; Karsten Hamm
Journal:  Catheter Cardiovasc Interv       Date:  2017-06-01       Impact factor: 2.692

View more
  1 in total

1.  The Association of Autoantibodies in Hyperthyroid Heart Disease Combined with Pulmonary Hypertension.

Authors:  Xiujuan Zhang; Lin Chen; Jianping Sheng; Chaoying Li; Yong He; WenXia Han
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.